Cargando…
Structural and Biochemical Features of Eimeria tenella Dihydroorotate Dehydrogenase, a Potential Drug Target
Dihydroorotate dehydrogenase (DHODH) is a mitochondrial monotopic membrane protein that plays an essential role in the pyrimidine de novo biosynthesis and electron transport chain pathways. In Eimeria tenella, an intracellular apicomplexan parasite that causes the most severe form of chicken coccidi...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7762340/ https://www.ncbi.nlm.nih.gov/pubmed/33297567 http://dx.doi.org/10.3390/genes11121468 |
_version_ | 1783627782265241600 |
---|---|
author | Sato, Dan Hartuti, Endah Dwi Inaoka, Daniel Ken Sakura, Takaya Amalia, Eri Nagahama, Madoka Yoshioka, Yukina Tsuji, Naotoshi Nozaki, Tomoyoshi Kita, Kiyoshi Harada, Shigeharu Matsubayashi, Makoto Shiba, Tomoo |
author_facet | Sato, Dan Hartuti, Endah Dwi Inaoka, Daniel Ken Sakura, Takaya Amalia, Eri Nagahama, Madoka Yoshioka, Yukina Tsuji, Naotoshi Nozaki, Tomoyoshi Kita, Kiyoshi Harada, Shigeharu Matsubayashi, Makoto Shiba, Tomoo |
author_sort | Sato, Dan |
collection | PubMed |
description | Dihydroorotate dehydrogenase (DHODH) is a mitochondrial monotopic membrane protein that plays an essential role in the pyrimidine de novo biosynthesis and electron transport chain pathways. In Eimeria tenella, an intracellular apicomplexan parasite that causes the most severe form of chicken coccidiosis, the activity of pyrimidine salvage pathway at the intracellular stage is negligible and it relies on the pyrimidine de novo biosynthesis pathway. Therefore, the enzymes of the de novo pathway are considered potential drug target candidates for the design of compounds with activity against this parasite. Although, DHODHs from E. tenella (EtDHODH), Plasmodium falciparum (PfDHODH), and human (HsDHODH) show distinct sensitivities to classical DHODH inhibitors, in this paper, we identify ferulenol as a potent inhibitor of both EtDHODH and HsDHODH. Additionally, we report the crystal structures of EtDHODH and HsDHODH in the absence and presence of ferulenol. Comparison of these enzymes showed that despite similar overall structures, the EtDHODH has a long insertion in the N-terminal helix region that assumes a disordered configuration. In addition, the crystal structures revealed that the ferulenol binding pocket of EtDHODH is larger than that of HsDHODH. These differences can be explored to accelerate structure-based design of inhibitors specifically targeting EtDHODH. |
format | Online Article Text |
id | pubmed-7762340 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-77623402020-12-26 Structural and Biochemical Features of Eimeria tenella Dihydroorotate Dehydrogenase, a Potential Drug Target Sato, Dan Hartuti, Endah Dwi Inaoka, Daniel Ken Sakura, Takaya Amalia, Eri Nagahama, Madoka Yoshioka, Yukina Tsuji, Naotoshi Nozaki, Tomoyoshi Kita, Kiyoshi Harada, Shigeharu Matsubayashi, Makoto Shiba, Tomoo Genes (Basel) Article Dihydroorotate dehydrogenase (DHODH) is a mitochondrial monotopic membrane protein that plays an essential role in the pyrimidine de novo biosynthesis and electron transport chain pathways. In Eimeria tenella, an intracellular apicomplexan parasite that causes the most severe form of chicken coccidiosis, the activity of pyrimidine salvage pathway at the intracellular stage is negligible and it relies on the pyrimidine de novo biosynthesis pathway. Therefore, the enzymes of the de novo pathway are considered potential drug target candidates for the design of compounds with activity against this parasite. Although, DHODHs from E. tenella (EtDHODH), Plasmodium falciparum (PfDHODH), and human (HsDHODH) show distinct sensitivities to classical DHODH inhibitors, in this paper, we identify ferulenol as a potent inhibitor of both EtDHODH and HsDHODH. Additionally, we report the crystal structures of EtDHODH and HsDHODH in the absence and presence of ferulenol. Comparison of these enzymes showed that despite similar overall structures, the EtDHODH has a long insertion in the N-terminal helix region that assumes a disordered configuration. In addition, the crystal structures revealed that the ferulenol binding pocket of EtDHODH is larger than that of HsDHODH. These differences can be explored to accelerate structure-based design of inhibitors specifically targeting EtDHODH. MDPI 2020-12-07 /pmc/articles/PMC7762340/ /pubmed/33297567 http://dx.doi.org/10.3390/genes11121468 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Sato, Dan Hartuti, Endah Dwi Inaoka, Daniel Ken Sakura, Takaya Amalia, Eri Nagahama, Madoka Yoshioka, Yukina Tsuji, Naotoshi Nozaki, Tomoyoshi Kita, Kiyoshi Harada, Shigeharu Matsubayashi, Makoto Shiba, Tomoo Structural and Biochemical Features of Eimeria tenella Dihydroorotate Dehydrogenase, a Potential Drug Target |
title | Structural and Biochemical Features of Eimeria tenella Dihydroorotate Dehydrogenase, a Potential Drug Target |
title_full | Structural and Biochemical Features of Eimeria tenella Dihydroorotate Dehydrogenase, a Potential Drug Target |
title_fullStr | Structural and Biochemical Features of Eimeria tenella Dihydroorotate Dehydrogenase, a Potential Drug Target |
title_full_unstemmed | Structural and Biochemical Features of Eimeria tenella Dihydroorotate Dehydrogenase, a Potential Drug Target |
title_short | Structural and Biochemical Features of Eimeria tenella Dihydroorotate Dehydrogenase, a Potential Drug Target |
title_sort | structural and biochemical features of eimeria tenella dihydroorotate dehydrogenase, a potential drug target |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7762340/ https://www.ncbi.nlm.nih.gov/pubmed/33297567 http://dx.doi.org/10.3390/genes11121468 |
work_keys_str_mv | AT satodan structuralandbiochemicalfeaturesofeimeriatenelladihydroorotatedehydrogenaseapotentialdrugtarget AT hartutiendahdwi structuralandbiochemicalfeaturesofeimeriatenelladihydroorotatedehydrogenaseapotentialdrugtarget AT inaokadanielken structuralandbiochemicalfeaturesofeimeriatenelladihydroorotatedehydrogenaseapotentialdrugtarget AT sakuratakaya structuralandbiochemicalfeaturesofeimeriatenelladihydroorotatedehydrogenaseapotentialdrugtarget AT amaliaeri structuralandbiochemicalfeaturesofeimeriatenelladihydroorotatedehydrogenaseapotentialdrugtarget AT nagahamamadoka structuralandbiochemicalfeaturesofeimeriatenelladihydroorotatedehydrogenaseapotentialdrugtarget AT yoshiokayukina structuralandbiochemicalfeaturesofeimeriatenelladihydroorotatedehydrogenaseapotentialdrugtarget AT tsujinaotoshi structuralandbiochemicalfeaturesofeimeriatenelladihydroorotatedehydrogenaseapotentialdrugtarget AT nozakitomoyoshi structuralandbiochemicalfeaturesofeimeriatenelladihydroorotatedehydrogenaseapotentialdrugtarget AT kitakiyoshi structuralandbiochemicalfeaturesofeimeriatenelladihydroorotatedehydrogenaseapotentialdrugtarget AT haradashigeharu structuralandbiochemicalfeaturesofeimeriatenelladihydroorotatedehydrogenaseapotentialdrugtarget AT matsubayashimakoto structuralandbiochemicalfeaturesofeimeriatenelladihydroorotatedehydrogenaseapotentialdrugtarget AT shibatomoo structuralandbiochemicalfeaturesofeimeriatenelladihydroorotatedehydrogenaseapotentialdrugtarget |